Scientists track rare genetic hearing loss over time

NCT ID NCT05572073

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows up to 150 people with hearing loss caused by changes in the otoferlin gene. Researchers will measure hearing function using tests like auditory brainstem response (ABR) and otoacoustic emissions (OAE). The goal is to learn how this type of hearing loss changes over time, which can help design future treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OTOFERLIN GENE-MEDIATED HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ankara University

    RECRUITING

    Ankara, Turkey, 06230, Turkey (Türkiye)

  • Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Cincinnati Children's Hospital Medical Center

    RECRUITING

    Cincinnati, Ohio, 45229, United States

  • Murdoch Children's Research Institute

    WITHDRAWN

    Parkville, Victoria, VIC 3052, Australia

  • National Taiwan University Hospital

    RECRUITING

    Taipei, 100, Taiwan

  • Sant Joan de Déu Barcelona Hospital

    RECRUITING

    Esplugues de Llobregat, Barcelona, 08950, Spain

  • University College London

    RECRUITING

    London, United Kingdom, NW1 2PG, United Kingdom

  • University Hospital in Tübingen

    RECRUITING

    Tübingen, 72076, Germany

  • University of Iowa

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232-8605, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.